Polly A. Murphy insider trades: Atea Pharmaceuticals (AVIR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Polly reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | AVIR | ↑ Buy | 6,100 | $4.17 | $25K | Direct | May 21, 2026 (3d) |
| May 18, 2025 | AVIR | ↑ Buy | 6,100 | $4.17 | $25K | Direct | May 20, 2026 (367d) |
| Nov 22, 2022 | CELC | ↑ Buy | 5,000 | $9.68 | $48K | Direct | Nov 23, 2022 (1d) |
| Dec 20, 2021 | AVIR | ↑ Buy | 12,000 | $8.57 | $103K | Direct | Dec 21, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Polly A. Murphy's insider trades
Polly A. Murphy is an insider at Atea Pharmaceuticals (AVIR). Since Dec 20, 2021, Polly has reported 4 open-market purchases worth $202K and no sales on SEC Form 4. In the last 12 months: 1 buy ($25K).
Their filings also include grants and awards (11 filings), option exercises (3 filings), gifts (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.